RGC68
Could you please elaborate on this?
"DATA! The phase 2a data was a) not statistically significant, and b) showed that BIT225 is 50 to 1000 times less potent than protease inhibitors (perfectly understandable because of its mechanism of action, and not necessarily a huge problem, but it isn't going to be a 'headline drug' in HCV with those figures).
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.654M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 49 | 31975625 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 14366964 | 19 |
View Market Depth
| Last trade - 16.30pm 18/07/2025 (20 minute delay) ? |
| BIT (ASX) Chart |
Day chart unavailable